Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis

Prevalence ofAspergillussensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis

(2015) V. N. Maturu et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Omalizumab in the management of steroid dependent Allergic Bronchopulmonary Aspergillosis (ABPA) complicating Cystic Fibrosis

(2013) Rachel Wong et al.   Paediatric Respiratory Reviews

Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: A synthesis of published evidence

(2013) Kalliopi Tanou et al.   PEDIATRIC PULMONOLOGY

Management of allergic bronchopulmonary aspergillosis: a review and update

(2012) Mahboobeh Mahdavinia et al.   Therapeutic Advances in Respiratory Disease

Allergic Bronchopulmonary Aspergillosis and Related Allergic Syndromes

(2011) Celia Hogan et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis

(2009) Malena Cohen-Cymberknoh et al.   Journal of Cystic Fibrosis

Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis

(2008) Jacquelyn M. Zirbes et al.   PEDIATRIC PULMONOLOGY

Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab)

(2008) Adaobi Kanu et al.   PEDIATRIC PULMONOLOGY